<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The c-myc gene is expressed in a variety of actively growing cells and tissues including lymphoblastoid cell lines made in vitro by <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> (Hamlyn &amp; Rabbitts 1983) </plain></SENT>
<SENT sid="1" pm="."><plain>The gene is implicated in the derivation of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> because of its association with consistent chromosomal translocations (Dalla-Favera et al </plain></SENT>
<SENT sid="2" pm="."><plain>1982; Neel et al </plain></SENT>
<SENT sid="3" pm="."><plain>1982; Taub et al </plain></SENT>
<SENT sid="4" pm="."><plain>1982) and in, for example, some colon <z:mp ids='MP_0002038'>carcinomas</z:mp> where the gene is amplified (Alitalo et al </plain></SENT>
<SENT sid="5" pm="."><plain>1983) </plain></SENT>
<SENT sid="6" pm="."><plain>To understand the formation of these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, we must determine the function of the c-myc protein in the cell </plain></SENT>
<SENT sid="7" pm="."><plain>In this discussion we describe some features of c-myc metabolism which indicate that its expression may normally be strictly modulated; it is possible that the potential oncogenic effect of c-myc in various <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> is the result of loss of this ability to modulate its activity </plain></SENT>
</text></document>